PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.76%
Some net income increase while MCHP is negative at -67.89%. John Neff would see a short-term edge over the struggling competitor.
-2.80%
Negative yoy D&A while MCHP is 3.63%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
56.86%
Well above MCHP's 70.64% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-16.00%
Both cut yoy SBC, with MCHP at -6.44%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
238.74%
Slight usage while MCHP is negative at -664.10%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
89.81%
AR growth while MCHP is negative at -407.79%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
82.81%
Some inventory rise while MCHP is negative at -10.08%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
123.08%
AP growth well above MCHP's 244.10%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
742.31%
Growth well above MCHP's 133.98%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-384.38%
Both negative yoy, with MCHP at -5.25%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
47.26%
Some CFO growth while MCHP is negative at -6.02%. John Neff would note a short-term liquidity lead over the competitor.
-45.21%
Negative yoy CapEx while MCHP is 15.60%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
45.21%
Acquisition growth of 45.21% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
7.44%
Less growth in investment purchases vs. MCHP's 100.00%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
211.18%
Liquidation growth of 211.18% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-45.91%
We reduce yoy other investing while MCHP is 1.95%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
54.50%
Investing outflow well above MCHP's 17.44%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-7.32%
Negative yoy issuance while MCHP is 76.99%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.